Design and Rationale of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)

被引：0
|
作者：
Pieske, B. [1 ]
Butler, J. [2 ]
Filippatos, G. [3 ]
Lam, C. [4 ]
Maggioni, A. [5 ]
Ponikowski, P. [6 ]
Shah, S. [7 ]
Solomon, S. [8 ]
Roessig, L. [9 ]
Gheorghiade, M.
机构：
[1] Med Univ Graz, Graz, Austria
[2] Emory Univ Hosp, Atlanta, GA 30322 USA
[3] Univ Athens, Athens, Greece
[4] Natl Univ Heart Ctr, Singapore, Singapore
[5] ANMCO Fdn Your Heart, Florence, Italy
[6] Mil Hosp Wroclaw, Wroclaw, Poland
[7] Northwestern Univ, Chicago, IL 60611 USA
[8] Brigham & Womens Hosp, Boston, MA 02115 USA
[9] Bayer Pharma AG, Wuppertal, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [41] Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure
    Boerrigter, G
    Costello-Boerrigter, LC
    Cataliotti, A
    Tsuruda, T
    Harty, GJ
    Lapp, H
    Stasch, JP
    Burnett, JC
    CIRCULATION, 2003, 107 (05) : 686 - 689
  • [42] Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with renal impairment
    Reiner Frey
    Corina Becker
    Sigrun Unger
    Anja Schmidt
    Georg Wensing
    Wolfgang Mueck
    BMC Pharmacology and Toxicology, 14 (Suppl 1)
  • [43] Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
    Belik, Jaques
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 971 - 979
  • [44] Soluble Guanylate Cyclase (sGC) Stimulator Reduces The Cardiac And Renal Damage In Angiotensin II (Ang II)-induced Diastolic Heart Failure
    Haase, Nadine
    Wilck, Nicola
    Marko, Lajos
    Heuser, Arnd
    Brockschnieder, Damian
    Kretschmer, Axel
    Stasch, Johannes-Peter
    Dechend, Ralf
    Muller, Dominik N.
    HYPERTENSION, 2014, 64
  • [45] Cardiorenal actions of the novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure in comparison to nitroglycerin
    Boerrigter, G
    Costello-Boerrigter, LC
    Lapp, H
    Cataliotti, A
    Tsuruda, T
    Harty, GJ
    Stasch, JP
    Burnett, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 253A - 254A
  • [46] Soluble Guanylate Cyclase Stimulator, BAY41-8543: A Promising Approach for the Treatment of Chronic Heart Failure Caused by Pressure and Volume Overload
    Martiskova, Adriana
    Sykora, Matus
    Andelova, Natalia
    Ferko, Miroslav
    Gawrys, Olga
    Andelova, Katarina
    Kala, Petr
    Cervenka, Ludek
    Bacova, Barbara Szeiffova
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2025, 13 (02):
  • [47] Soluble Guanylate Cyclase Activation With Cinaciguat A New Approach to the Treatment of Decompensated Heart Failure
    Hingorany, Shipra
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2011, 19 (01) : 23 - 29
  • [48] Pharmacological Effects of a New Soluble Guanylate Cyclase Stimulator in Experimental Ischemic Stroke
    Bykov, V. V.
    Bykova, A. V.
    Motov, V. S.
    Larchenko, V. V.
    Chernysheva, G. A.
    Smol'yakova, V. I.
    Aliev, O. I.
    Khazanov, V. A.
    Vengerovskii, A. I.
    Udut, V. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 175 (06) : 749 - 752
  • [49] Anti-Atherosclerotic Action of a New Stimulator of Soluble Guanylate Cyclase in an Experiment
    Bykov, V. V.
    Bykova, A. V.
    Dzyuman, A. N.
    Ivanov, V. V.
    Khazanov, V. A.
    Vengerovskii, A. I.
    Udut, V. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 174 (03) : 333 - 336
  • [50] Inhibition of fibrosis and inflammation by a soluble guanylate cyclase stimulator in models of liver disease
    Hall, Katherine
    Jacobson, Sarah
    Zhang, Ping
    Liu, Guang
    Sarno, Renee
    Catanzano, Victoria
    Bernier, Sylvie
    Currie, Mark
    Masferrer, Jaime
    HEPATOLOGY, 2017, 66 : 1073A - 1074A
12345